Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients
Public ClinicalTrials.gov record NCT06126497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study Evaluating the Safety and Efficacy of Ropanicant in Participants With Moderate to Severe Major Depressive Disorder
Study identification
- NCT ID
- NCT06126497
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Suven Life Sciences Limited
- Industry
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Interventions
- Ropanicant Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 4, 2024
- Primary completion
- Jul 18, 2024
- Completion
- Jul 18, 2024
- Last update posted
- Apr 7, 2026
2024
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Innovations, Inc | Bellflower | California | 90706 | — |
| NRC Research Institute | Orange | California | 92868 | — |
| Collaborative Neuroscience Research, LLC | Torrance | California | 90504 | — |
| Innovative Clinical Research, Inc. | Miami Lakes | Florida | 33016 | — |
| CenExel iResearch, LLC | Decatur | Georgia | 30030 | — |
| CenExel iResearch, LLC | Savannah | Georgia | 31405 | — |
| Precise Research Centers | Flowood | Mississippi | 39232 | — |
| Neuro behavioral Clinical Research, Inc | North Canton | Ohio | 44720 | — |
| Cedar Clinical Research, Inc. | Murray | Utah | 84107 | — |
| Eastside Therapeutic Resource, Inc. dba Core Clinical Research | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06126497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06126497 live on ClinicalTrials.gov.